All Articles
Pharma Communication and Education for Stakeholders (Personalized Medicine: What Pharma Should Do to Get Ready)

Pharma Communication and Education for Stakeholders (Personalized Medicine: What Pharma Should Do to Get Ready)

21 October, 2015

In Part 5 of the series, ‘Personalized Medicine: What Pharma Should Do to Get Ready', Tessa Sandberg of Diaceutics discusses how pharmaceutical companies should communicate with and educate stakeholders to ensure test adoption.|In Part 5 of the series, ‘Personalized Medicine: What Pharma Should Do to Get Ready', Tessa Sandberg of Diaceutics discusses how pharmaceutical companies should communicate with and educate stakeholders to ensure test adoption.|In Part 5 of the series, ‘Personalized Medicine: What Pharma Should Do to Get Ready', Tessa Sandberg of Diaceutics discusses how pharmaceutical companies should communicate with and educate stakeholders to ensure test adoption.|In Part 5 of the series, ‘Personalized Medicine: What Pharma Should Do to Get Ready', Tessa Sandberg of Diaceutics discusses how pharmaceutical companies should communicate with and educate stakeholders to ensure test adoption.

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.